A clear guide to GLP-1 receptor agonists, the class of medications behind Ozempic, Wegovy, and more. Learn what they are, how they work in the body, and how the different options compare for diabetes and weight loss.
GLP-1 Agonists
Stopping GLP-1 medications often leads to weight regain, but a new study from Dartmouth suggests an outpatient endoscopic procedure could help patients maintain their results. This article breaks down how it works, who might benefit, and what questions to ask your doctor before pursuing this option.
Novo Nordisk has released positive early response data from its oral semaglutide 25mg trial, the pill version of Wegovy. Here's what the findings mean for patients currently on injectable GLP-1s and those who have been waiting for a needle-free option.
Insurance coverage for GLP-1 medications like semaglutide and tirzepatide is shrinking even as demand grows. If you've been denied coverage or are worried about costs, here's what you can actually do about it. This guide breaks down your real options from appeals to compounding pharmacies.
Stopping GLP-1 medications like Ozempic often leads to rapid weight regain, a phenomenon known as the "Ozempic rebound." Oral GLP-1 pills in development may offer a more sustainable, lower-barrier path forward. Here is what patients need to know right now.
Walgreens has positioned itself as more than just a pharmacy for GLP-1 users, offering services that go beyond simply filling prescriptions. But how useful are these offerings in practice, and where do independent resources fill the gaps? Here's what GLP-1 patients should know.
GLP-1 medications like semaglutide and tirzepatide are doing far more than helping people lose weight. They are fundamentally changing how diabetes is treated and how pharmacists and providers work together to care for patients. Here is what that shift means for you.
Novo Nordisk has reported that a higher-dose formulation of Wegovy (semaglutide) helped certain patients lose nearly 28% of their body weight. This is a meaningful jump from the results seen with the current standard dose. Here's what patients and prospective users should know before their next doctor's visit.
A new Medicare program could dramatically lower the cost of GLP-1 weight-loss medications for millions of eligible Americans. Here's what the coverage changes mean for your wallet, your provider options, and how to take advantage of expanded access.
